Sign In

What's New

Jul 27
The U.S. Food and Drug Administration has approved Daklinza (daclatasvir) for use with sofosbuvir to treat hepatitis C virus (HCV) genotype 3 infections.
Jul 27
A new study by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), the National Cancer Institute, and the Chulabhorn Research Institute has found that blocking the activity of a...
Jul 23
A gene mutation has been found to contribute to non-alcoholic fatty liver disease (NAFLD), a form of liver disease closely linked to obesity, in normal weight subjects.

Member Spotlight

Carol Casey, PhD, FAASLD

Dr. Casey is Professor of Internal Medicine and Biochemistry at University of Nebraska College of Medicine and a Research Career Scientist at the Omaha Department of Veteran’s Affairs.